Cat.#: ACPP-1338
Despition | Dopamine Receptor D1 Blocking Peptide for Immunodepletion, Immunocompetition |
SIZE | 250 µg |
Applications | Immunodepletion & Immunocompetition assay |
Storage | Store at -20⁰C for long term |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1247 | GSK3 beta Blocking Peptide (AC1247) | 250 µg | inquiry |
ACPP-1616 | Human DGCR6 Protein (AC1616) | 5 µg | inquiry |
ACPP-1152 | PAX5 Blocking Peptide (AC1152) | 250 µg | inquiry |
ACPP-1238 | LIMK1 Blocking Peptide (AC1238) | 250 µg | inquiry |
ACPP-1825 | Human ANKRA2 Protein (AC1825) | 2 µg | inquiry |
ACPP-1269 | Mouse GDNF Protein (AC1269) | 2 µg | inquiry |
ACPP-1322 | TRPM8 Blocking Peptide (AC1322) | 250 µg | inquiry |
ACPP-1116 | Recombinant Human L1CAM Protein (6×His Tag) (AC1116) | 50 µg | inquiry |
ACPP-1568 | Human NME4 Protein (AC1568) | 5 µg | inquiry |
ACPP-1448 | Human I TAC Protein, His (AC1448) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.